Aarti Intangible Assets vs Accounts Payable Analysis

AARTIDRUGS   460.80  2.40  0.52%   
Aarti Drugs financial indicator trend analysis is way more than just evaluating Aarti Drugs Limited prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aarti Drugs Limited is a good investment. Please check the relationship between Aarti Drugs Intangible Assets and its Accounts Payable accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

Intangible Assets vs Accounts Payable

Intangible Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aarti Drugs Limited Intangible Assets account and Accounts Payable. At this time, the significance of the direction appears to have no relationship.
The correlation between Aarti Drugs' Intangible Assets and Accounts Payable is 0.07. Overlapping area represents the amount of variation of Intangible Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Aarti Drugs Limited, assuming nothing else is changed. The correlation between historical values of Aarti Drugs' Intangible Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Intangible Assets of Aarti Drugs Limited are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Intangible Assets i.e., Aarti Drugs' Intangible Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.07
Relationship DirectionPositive 
Relationship StrengthInsignificant

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Accounts Payable

An accounting item on the balance sheet that represents Aarti Drugs obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Aarti Drugs Limited are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Aarti Drugs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aarti Drugs Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aarti Drugs Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
As of 11/30/2024, Selling General Administrative is likely to grow to about 1.1 B, while Tax Provision is likely to drop slightly above 566.4 M.
 2021 2022 2023 2024 (projected)
Interest Expense207.5M332.9M378.9M315.0M
Depreciation And Amortization500.5M503.2M514.5M367.1M

Aarti Drugs fundamental ratios Correlations

0.790.020.940.850.970.770.610.97-0.090.750.97-0.240.690.98-0.15-0.170.970.990.80.990.230.830.390.510.06
0.79-0.270.860.590.831.00.30.83-0.020.480.73-0.110.650.69-0.19-0.040.890.740.480.740.190.570.390.73-0.01
0.02-0.27-0.180.220.08-0.26-0.330.07-0.17-0.150.0-0.340.250.01-0.19-0.29-0.08-0.010.120.05-0.320.250.1-0.420.36
0.940.86-0.180.740.890.840.620.89-0.070.740.94-0.130.530.92-0.07-0.130.970.940.680.930.320.710.380.64-0.11
0.850.590.220.740.820.570.570.820.020.690.82-0.690.60.84-0.1-0.090.780.850.950.880.081.00.270.450.44
0.970.830.080.890.820.820.451.0-0.130.590.9-0.230.790.92-0.21-0.180.950.930.730.930.160.810.350.440.14
0.771.0-0.260.840.570.820.260.82-0.030.450.71-0.10.660.67-0.18-0.040.880.720.460.720.170.550.390.710.0
0.610.3-0.330.620.570.450.260.470.060.860.66-0.230.160.71-0.11-0.030.550.680.660.690.550.550.050.49-0.11
0.970.830.070.890.821.00.820.47-0.120.610.91-0.230.780.92-0.19-0.180.950.930.730.930.170.810.340.450.15
-0.09-0.02-0.17-0.070.02-0.13-0.030.06-0.120.12-0.19-0.02-0.38-0.030.270.94-0.17-0.070.23-0.08-0.52-0.010.180.40.2
0.750.48-0.150.740.690.590.450.860.610.120.82-0.250.260.82-0.070.00.680.830.750.810.360.660.440.65-0.1
0.970.730.00.940.820.90.710.660.91-0.190.82-0.220.60.96-0.11-0.270.940.990.770.970.320.80.410.5-0.04
-0.24-0.11-0.34-0.13-0.69-0.23-0.1-0.23-0.23-0.02-0.25-0.22-0.32-0.250.110.08-0.2-0.23-0.61-0.320.02-0.720.06-0.21-0.68
0.690.650.250.530.60.790.660.160.78-0.380.260.6-0.320.62-0.52-0.390.720.610.460.650.170.630.220.20.18
0.980.690.010.920.840.920.670.710.92-0.030.820.96-0.250.62-0.11-0.120.930.990.840.990.260.830.370.50.01
-0.15-0.19-0.19-0.07-0.1-0.21-0.18-0.11-0.190.27-0.07-0.110.11-0.52-0.110.32-0.2-0.12-0.07-0.14-0.09-0.11-0.11-0.090.2
-0.17-0.04-0.29-0.13-0.09-0.18-0.04-0.03-0.180.940.0-0.270.08-0.39-0.120.32-0.22-0.150.11-0.18-0.46-0.120.230.290.12
0.970.89-0.080.970.780.950.880.550.95-0.170.680.94-0.20.720.93-0.2-0.220.950.690.950.310.760.370.58-0.04
0.990.74-0.010.940.850.930.720.680.93-0.070.830.99-0.230.610.99-0.12-0.150.950.820.990.260.820.410.530.0
0.80.480.120.680.950.730.460.660.730.230.750.77-0.610.460.84-0.070.110.690.820.83-0.030.930.320.450.36
0.990.740.050.930.880.930.720.690.93-0.080.810.97-0.320.650.99-0.14-0.180.950.990.830.290.870.360.540.07
0.230.19-0.320.320.080.160.170.550.17-0.520.360.320.020.170.26-0.09-0.460.310.26-0.030.290.09-0.250.17-0.22
0.830.570.250.711.00.810.550.550.81-0.010.660.8-0.720.630.83-0.11-0.120.760.820.930.870.090.240.430.48
0.390.390.10.380.270.350.390.050.340.180.440.410.060.220.37-0.110.230.370.410.320.36-0.250.240.35-0.31
0.510.73-0.420.640.450.440.710.490.450.40.650.5-0.210.20.5-0.090.290.580.530.450.540.170.430.35-0.01
0.06-0.010.36-0.110.440.140.0-0.110.150.2-0.1-0.04-0.680.180.010.20.12-0.040.00.360.07-0.220.48-0.31-0.01
Click cells to compare fundamentals

Aarti Drugs Account Relationship Matchups

Aarti Drugs fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets15.8B17.7B22.1B24.2B24.3B12.7B
Short Long Term Debt Total3.9B3.5B5.4B6.1B5.6B4.3B
Other Current Liab890.1M521.7M(435M)445.2M567.2M595.5M
Total Current Liabilities6.2B6.0B9.4B9.3B8.0B5.0B
Total Stockholder Equity6.5B9.1B10.4B11.9B12.8B13.5B
Property Plant And Equipment Net6.5B6.8B7.7B8.9B10.5B5.4B
Net Debt3.8B3.4B5.2B6.0B5.6B4.2B
Cash67.7M88.1M216.1M89.6M67.4M65.7M
Non Current Assets Total6.8B7.1B8.1B9.3B11.1B5.7B
Non Currrent Assets Other(6.7B)72.6M284.4M236.7M9.0M9.4M
Cash And Short Term Investments67.7M88.1M216.1M211.7M89.3M74.5M
Net Receivables5.7B5.6B7.6B8.6B7.0B4.1B
Liabilities And Stockholders Equity15.8B17.7B22.1B24.2B24.3B12.7B
Non Current Liabilities Total3.0B2.6B2.3B3.0B3.5B2.6B
Inventory3.3B4.2B5.3B5.2B4.9B2.5B
Other Current Assets365.8M645.8M825.6M900.5M1.2B863.3M
Other Stockholder Equity(6.4B)664.3M650.1M(47.0K)15K15.8K
Total Liab9.2B8.5B11.7B12.3B11.5B7.6B
Total Current Assets9.0B10.6B13.9B14.9B13.2B7.1B
Accumulated Other Comprehensive Income(3.9B)664.3M650.1M793.0M343.7M360.8M
Accounts Payable3.3B3.3B4.7B4.8B4.5B2.8B
Current Deferred Revenue927.0M(396.1M)1.1B43.7M11.8M11.2M
Retained Earnings5.9B7.5B8.8B10.2B11.6B12.1B
Other Assets2K11.5M1K72.6M236.7M0.95
Short Term Debt2.0B2.0B4.0B4.0B2.9B3.1B
Intangible Assets14.9M2.6M1.5M7.9M368.2M386.7M
Short Term Investments114.2M127.2M126.4M122.1M21.9M20.8M
Other Liab1.1B1.1B912.2M906.7M1.0B949.0M
Net Tangible Assets6.5B9.1B10.4B11.9B13.7B14.4B
Long Term Debt1.8B1.5B1.4B2.0B2.8B2.0B
Short Long Term Debt2.0B1.6B4.0B4.0B2.9B2.8B
Property Plant Equipment6.5B6.8B7.7B8.9B10.2B6.8B
Long Term Debt Total1.9B1.5B1.4B2.1B1.8B1.5B
Non Current Liabilities Other17.4M(32K)(3K)(33K)(58K)(55.1K)
Net Invested Capital10.3B12.2B15.7B18.0B18.4B15.0B
Net Working Capital2.7B4.6B4.5B5.6B5.3B4.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Aarti Stock Analysis

When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.